CSU Vaccination Against Canine Cancer Study

26/06/2019

The Vaccination Against Canine Cancer Study (VACCS trial) will be the largest clinical trial conducted to date for canine cancer...
 
As part of the largest interventional canine clinical trial ever conducted, veterinarians leading the Vaccine Against Canine Cancer Study seek to enroll 800 healthy, middle-aged pet dogs to evaluate the effectiveness of a new cancer prevention vaccine.

The goal of the VACCS trial is to evaluate a new vaccine strategy for the prevention, rather than treatment of dogs with cancer. Healthy dogs of certain breeds, 6 years or older, will be randomized to receive either a series of vaccines similar to other routine vaccines that are given to dogs currently, or placebo vaccines. Dogs will live at home and be checked 2-3 times yearly for 5 years after enrollment.

In addition to potentially providing a new strategy for cancer prevention in dogs, if successful, this study could provide important justification for eventually looking at a similar approach in humans.

For further information check out the following resources: Check out the Oncology category on Vetlexicon Canis for more information on canine cancer. Amongst others, topics include:
Image: Myeloma: thorax - radiograph lateral ©University of Cambridge

ADDED